Neurocrine Biosciences, Inc. (NBIX) Earnings
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$128.41
+0.46%
Mkt Cap $13.07B
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
$1.68
9 analysts
Revenue Estimate
$766.57M
Last quarter: beat by +4.44% on EPS, +1.90% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$13.07B
P/E
27.47
Fwd P/E
11.88
P/S
4.57
Rev TTM
—
EPS TTM
$4.66